Biotech
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 05/09/13 -- Sernova Corp. (TSX VENTURE: SVA), provides a corporate update on the clinical development of the Cell Pouch™ and projections for 2013. As well, it i ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/08/13 -- Pacgen Life Science Corporation ("Pacgen") (TSX VENTURE: PBS) announced today that Dr. Ming S. Liu has stepped down as Chief Exe ...
MT. FREEDOM, NJ: The Sturge-Weber Foundation Applauds Research and Urges Continued Collaboration to Bring New Hope to Families Living With Rare Disorder ...
SAN FRANCISCO, CA: Top-Line Data From TRAVERSE, Phase 2b Pexa-Vec Trial in Hepatocellular Carcinoma, Expected at Year End ...
LAVAL, QUEBEC: - Revenues of $4.4 million in Q1 2013, an increase of $3.3 million compared to Q1 2012 - Revenues expected to exceed $11.0 million by the end of June 2013, compared to $7.4 million for the first half ...
CARY, NC: CARY, NC -- (Marketwired) -- 05/08/13 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, May 9, 2013, to discuss its fina ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 05/07/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") is pleased to announce that Russell J. H ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 05/07/13 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that develops and commercializes innovative supportive care products, today ann ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwired) -- 05/07/13 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced that it has initiated dosing in a Phase 1 mu ...
NEW YORK, NY: Potential Best-in-Class Oral Testosterone Replacement Therapy Poised for Phase III Trial; Pipeline Candidates Include Once-Daily Oral TRT and Potential First Oral Drug for the Prevention of Preterm Bi ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 05/07/13 -- Linkage Biosciences, a molecular diagnostics company and leader in Human Leukocyte Antigen (HLA) typing and associated products, announced that it re ...
BAGNEUX, FRANCE: BAGNEUX, FRANCE -- (Marketwired) -- 05/07/13 -- DBV Technologies (EURONEXT PARIS: DBV) (ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, announced today a part ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 05/06/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:David Hung, M.D., president and chief executive off ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 05/06/13 -- Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) ("Bradmer" or the "Company") today announced its first quarter 2013 operational ...
BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 05/06/13 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the first quarter ended March 31, 2013. The Company had $105.4 millio ...
PRINCETON, NJ: Two Poster Presentations Include Combined Data From Two Phase 3 Studies ...
LONDON, ONTARIO: Critical Outcome Technologies provides update on progress to date ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/03/13 -- RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF)(CNSX: RP) reports that its Chief Scientific O ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 05/03/13 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE), is pleased to advise that it has executed an agreement with Three Rivers Provider Network, ...
